Has Sizan Patel, MD received payments from drug or device companies?

Yes. Drug and device makers reported $480 in general payments to Sizan Patel, MD across 12 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sizan Patel, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sizan Patel, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sizan Patel, MD

Internal Medicine · Toms River, NJNPI 1043655368

Payments from drug & device makers

$480in general payments, 2019–2025

Across 12 payments — averaging $40.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Davol Inc.$150
Exact Sciences$142
BD$121
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$19
Lundbeck LLC$18
Novo Nordisk$17
plus $13 from 1 others

What the payments were for

Food & beverage$480100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Davol Inc.	1	$150
Exact Sciences	6	$142
BD	1	$121
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	1	$19
Lundbeck LLC	1	$18
Novo Nordisk	1	$17
Nestle Healthcare Nutrition Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Phasix Mesh$271

How this compares

$480 in reported general payments places this provider in the 55th percentile of 4,032 internal medicine providers in New Jersey.

See all internal medicine providers in New Jersey →

Medicare billing

Part B allowed, 2024

$222,928

Medicare patients

464

Services billed

1,895

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	107	$64,102
FarxigaDapagliflozin Propanediol	23	$28,634
JardianceEmpagliflozin	18	$25,536
OzempicSemaglutide	23	$22,301
Breo ElliptaFluticasone/Vilanterol	27	$15,832
XareltoRivaroxaban	27	$14,801
MyrbetriqMirabegron	29	$13,836
JanuviaSitagliptin Phosphate	17	$11,569
Spiriva RespimatTiotropium Bromide	17	$8,839
EntrestoSacubitril/Valsartan	13	$8,659
Fluticasone-VilanterolFluticasone/Vilanterol	16	$5,912
Atorvastatin Calcium	259	$3,603
Pantoprazole Sodium	118	$2,998
Albuterol Sulfate HfaAlbuterol Sulfate	100	$2,966
Metoprolol Succinate	137	$2,132

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Novo NordiskOzempic	$17	$22,30123 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 4,032 internal medicine providers in New Jersey.

Other internal medicine in Toms River

Sanjiv SharmaToms River$33.9M
Jeffrey CarsonNew Brunswick$13.8M
Samer HaddadHamilton$6.8M
Magdy ShenoudaWall$3.7M
Samar HameedLivingston$3.6M
Jane RohlfTrenton$2.7M
Mohammed NisarEdison$2.6M
Michael CasserNew Milford$2.2M
Sumitha ReddyHamilton$2M
Helio PedroNewark$1.8M

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →